AFT Pharmaceuticals gets greenlight for nine additional European countries

AFT Pharmaceuticals gets greenlight for nine additional European countries
Rebecca Howard
By Rebecca Howard May 19 (BusinessDesk) -  AFT Pharmaceuticals obtained regulatory approval to sell its Maxigesic painkiller in nine additional European countries, a move that lets it ramp up international sales of its tablets.  The Auckland-based drug maker said the European Medicines Agency approved Maxigesic tablets in Austria, Belgium, Croatia, France, Germany, Luxembourg, Netherlands, Portugal and Spain. These countries have been added to the existing European countries where Maxigesic has been approved for sale. "Collectively the...